Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

Presentation THT 2025

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Presenter: Javed Butler

February 11, 2025

Presentation TCT 2024

TCT 112: The Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy

Presenter: Kazuki Muramatsu

October 29, 2024

Presentation NY Valves 2024

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Presenter: Francesca Isabella Galasso

June 05, 2024

Presentation TVT 2023

Position 1: No Residual Shunt is Mandatory for PFO Closure Success

Presenter: Zachary Steinberg

June 09, 2023

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

News Industry News

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

July 14, 2021

News Daily News

Complete PFO Closure May Be Key for Migraine Reduction

Todd Neale

February 04, 2020

Presentation

Comparison of Residual Shunt Rate and Complications: 6 Different PFO Closure Devices

October 30, 2019

News Daily News

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

Yael L. Maxwell

October 30, 2019

Presentation TCT 2019

Case Presentation (With Discussion): Residual Shunts After PFO Closure

Presenter: Jonathan Tobis

September 27, 2019

Presentation TVT 2019

Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale

Presenter: Eyal Ben Assa

June 14, 2019

News Conference News TCT 2017

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Yael L. Maxwell

October 31, 2017

News Daily News

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Shelley Wood

May 25, 2016

News Industry News

HeartStitch® Launches German Sales of NobleStitch™ EL

May 02, 2016

News Daily News

CAD Extent May Foreshadow Risk of Heart Failure After First MI

L.A. McKeown

March 31, 2016

News Industry News

Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

February 02, 2016

News Daily News

Years Later, MIST Trial Investigator Suspended in Long-Running Controversy Over PFO-Closure Study Misconduct

Shelley Wood

December 03, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Daily News

A Mayor Edad, Mayor Riesgo de Isquemia Cerebral Recurrente en Pacientes sometidos al Cierre del FOP

Yael L. Maxwell

July 08, 2015

Advertisement

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

TCT 112: The Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Position 1: No Residual Shunt is Mandatory for PFO Closure Success

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

Complete PFO Closure May Be Key for Migraine Reduction

Comparison of Residual Shunt Rate and Complications: 6 Different PFO Closure Devices

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

Case Presentation (With Discussion): Residual Shunts After PFO Closure

Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

HeartStitch® Launches German Sales of NobleStitch™ EL

CAD Extent May Foreshadow Risk of Heart Failure After First MI

Top Swedish Heart Center Confirms PFO-Closure Benefits of NobleStitch™ EL Among Widening Patient Population

Years Later, MIST Trial Investigator Suspended in Long-Running Controversy Over PFO-Closure Study Misconduct

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

A Mayor Edad, Mayor Riesgo de Isquemia Cerebral Recurrente en Pacientes sometidos al Cierre del FOP

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content